Literature DB >> 29221277

Worse survival after curative resection in patients with pathological stage I non-small cell lung cancer adjoining pulmonary cavity formation.

Hiroyuki Kimura1, Hisashi Saji1,2, Tomoyuki Miyazawa1, Hiroki Sakai1, Masataka Tsuda1, Yoichi Wakiyama1, Hideki Marushima1, Koji Kojima1, Haruhiko Nakamura1.   

Abstract

BACKGROUND: A few investigators have suggested an association between lung cancer and pulmonary cavity. However, this clinical association and its carcinogenic correlations are not well recognized. This study aimed to clarify the clinical features and to demonstrate the associated survival outcomes after curative surgery in patients with early non-small cell lung cancer (NSCLC) adjoining pulmonary cavity formation.
METHODS: We retrospectively reviewed 275 patients with pathological stage I NSCLC by re-evaluating their chest computed tomography images. Among them, we detected NSCLC adjoining pulmonary cavity formation in 12 (4.4%) patients.
RESULTS: The median follow-up period for all 275 patients was 43.2 (range, 6.0-86.0) months. Of these patients, 6 (50.0%) in group CF (patients with NSCLC adjoining pulmonary cavity formation) and 19 (7.2%) in group C (the control group, n=263) died during the study period. Besides, 6 (50.0%) and 32 (12.2%) patients in groups CF and C, respectively, exhibited recurrence of the primary lung cancer. The cumulative overall survival (OS) in groups CF and C at 5 years was 37.0% and 91.7%, respectively (P<0.0001); the recurrence-free survival (RFS) in these groups at 5 years was 55.0% and 86.7%, respectively (P=0.001). Univariate analysis showed that male sex, smoking habits, non-adenocarcinoma, and presence of pulmonary cavity formation were associated with poor OS (P=0.008, P=0.001, P<0.0001, and P<0.0001, respectively). Multivariate analysis demonstrated that smoking, non-adenocarcinoma, and pulmonary cavity formation were independent prognostic factors predicting poor survival (P=0.043, P=0.004 and P<0.0001, respectively).
CONCLUSIONS: Our results suggest that patients with early-stage NSCLC adjoining pulmonary cavity formation have an increased risk of poor OS and RFS after surgical resection. Further prospective, multi-institutional investigations and substantial clinical studies are warranted.

Entities:  

Keywords:  Pulmonary cavity; bulla; lung cancer; prognostic factor; survival

Year:  2017        PMID: 29221277      PMCID: PMC5708480          DOI: 10.21037/jtd.2017.08.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  16 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

3.  Co-existing lobar adenocarcinoma and cystic disease of the lung.

Authors:  H E BASS; E SINGER
Journal:  Ann Intern Med       Date:  1951-02       Impact factor: 25.391

4.  Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema.

Authors:  Shin Matsuoka; Yasuyuki Kurihara; Kunihiro Yagihashi; Hiroshi Niimi; Yasuo Nakajima
Journal:  Radiology       Date:  2005-02-16       Impact factor: 11.105

5.  Bronchogenic carcinoma and giant bullous disease.

Authors:  M J Goldstein; G L Snider; M Liberson; R M Poske
Journal:  Am Rev Respir Dis       Date:  1968-06

6.  The risk of lung cancer in males with bullous disease of the lung.

Authors:  I L Stoloff; P Kanofsky; L Magilner
Journal:  Arch Environ Health       Date:  1971-01

Review 7.  Lung cancer associated with pulmonary bulla. case report and review of literature.

Authors:  D Ogawa; Y Shiota; M Marukawa; J Hiyama; H Mashiba; K Yunoki; S Imai; K Motohiro; N Sasaki; K Taniyama
Journal:  Respiration       Date:  1999 Nov-Dec       Impact factor: 3.580

8.  Lung cancer associated with cystic airspaces.

Authors:  Ali O Farooqi; Matt Cham; Lijuan Zhang; Mary Beth Beasley; John H M Austin; Albert Miller; Javier J Zulueta; Heidi Roberts; Cole Enser; Shang-Jyh Kao; M K Thorsen; James P Smith; Daniel M Libby; Rowena Yip; David F Yankelevitz; Claudia I Henschke
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

Review 9.  Characteristic radiographic features of pulmonary carcinoma associated with large bulla.

Authors:  M Tsutsui; Y Araki; T Shirakusa; S Inutsuka
Journal:  Ann Thorac Surg       Date:  1988-12       Impact factor: 4.330

10.  Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.

Authors:  Juan P de Torres; Gorka Bastarrika; Juan P Wisnivesky; Ana B Alcaide; Arantza Campo; Luis M Seijo; Jesús C Pueyo; Alberto Villanueva; María D Lozano; Usua Montes; Luis Montuenga; Javier J Zulueta
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

View more
  2 in total

1.  Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces.

Authors:  Woohyun Jung; Sukki Cho; Sungwon Yum; Jin-Haeng Chung; Kyung Won Lee; Kwhanmien Kim; Choon Taek Lee; Sanghoon Jheon
Journal:  Ann Surg Oncol       Date:  2020-05-03       Impact factor: 5.344

2.  Impact of the favorable prognosis of patients with lung cancer adjoining bullae.

Authors:  Shuichi Shinohara; Masakazu Sugaya; Takamitsu Onitsuka; Kazuhiko Machida; Masaki Matsuo; Kazuo Kato; Fumihiro Tanaka
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.